359 related articles for article (PubMed ID: 31881325)
1. Apoptosis and autophagy in polycystic kidney disease (PKD).
Nowak KL; Edelstein CL
Cell Signal; 2020 Apr; 68():109518. PubMed ID: 31881325
[TBL] [Abstract][Full Text] [Related]
2. What is the role of tubular epithelial cell apoptosis in polycystic kidney disease (PKD)?
Edelstein CL
Cell Cycle; 2005 Nov; 4(11):1550-4. PubMed ID: 16258272
[TBL] [Abstract][Full Text] [Related]
3. Autophagy induction promotes renal cyst growth in polycystic kidney disease.
Lee EJ; Ko JY; Oh S; Jun J; Mun H; Lim CJ; Seo S; Ko HW; Kim H; Oh YK; Ahn C; Kang M; Kim MJ; Yoo KH; Oh GT; Park JH
EBioMedicine; 2020 Oct; 60():102986. PubMed ID: 32949996
[TBL] [Abstract][Full Text] [Related]
4. Polycystic kidney disease: a case of suppressed autophagy?
Ravichandran K; Edelstein CL
Semin Nephrol; 2014 Jan; 34(1):27-33. PubMed ID: 24485027
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis in polycystic kidney disease: involvement of caspases.
Ali SM; Wong VY; Kikly K; Fredrickson TA; Keller PM; DeWolf WE; Lee D; Brooks DP
Am J Physiol Regul Integr Comp Physiol; 2000 Mar; 278(3):R763-9. PubMed ID: 10712299
[TBL] [Abstract][Full Text] [Related]
6. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.
Tao Y; Kim J; Faubel S; Wu JC; Falk SA; Schrier RW; Edelstein CL
Proc Natl Acad Sci U S A; 2005 May; 102(19):6954-9. PubMed ID: 15863619
[TBL] [Abstract][Full Text] [Related]
7. Autophagy activators suppress cystogenesis in an autosomal dominant polycystic kidney disease model.
Zhu P; Sieben CJ; Xu X; Harris PC; Lin X
Hum Mol Genet; 2017 Jan; 26(1):158-172. PubMed ID: 28007903
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis in polycystic kidney disease.
Goilav B
Biochim Biophys Acta; 2011 Oct; 1812(10):1272-80. PubMed ID: 21241798
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation.
Wu M; Gu J; Mei S; Xu D; Jing Y; Yao Q; Chen M; Yang M; Chen S; Yang B; Qi N; Hu H; Wüthrich RP; Mei C
Nephrol Dial Transplant; 2016 Nov; 31(11):1826-1834. PubMed ID: 27190325
[TBL] [Abstract][Full Text] [Related]
10. Mammalian target of rapamycin and caspase inhibitors in polycystic kidney disease.
Edelstein CL
Clin J Am Soc Nephrol; 2008 Jul; 3(4):1219-26. PubMed ID: 18587045
[TBL] [Abstract][Full Text] [Related]
11. The consequences of increased 4E-BP1 in polycystic kidney disease.
Holditch SJ; Brown CN; Atwood DJ; Pokhrel D; Brown SE; Lombardi AM; Nguyen KN; Hill RC; Lanaspa M; Hopp K; Weiser-Evans MCM; Edelstein CL
Hum Mol Genet; 2019 Dec; 28(24):4132-4147. PubMed ID: 31646342
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1.
Shillingford JM; Piontek KB; Germino GG; Weimbs T
J Am Soc Nephrol; 2010 Mar; 21(3):489-97. PubMed ID: 20075061
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney Disease.
Idowu J; Home T; Patel N; Magenheimer B; Tran PV; Maser RL; Ward CJ; Calvet JP; Wallace DP; Sharma M
Sci Rep; 2018 Feb; 8(1):3340. PubMed ID: 29463793
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of exogenous kidney-specific Ngal attenuates progressive cyst development and prolongs lifespan in a murine model of polycystic kidney disease.
Wang E; Chiou YY; Jeng WY; Lin HK; Lin HH; Chin HJ; Leo Wang CK; Yu SS; Tsai SC; Chiang CY; Cheng PH; Lin HJ; Jiang ST; Chiu ST; Hsieh-Li HM
Kidney Int; 2017 Feb; 91(2):412-422. PubMed ID: 28341240
[TBL] [Abstract][Full Text] [Related]
15. Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease.
Parker MI; Nikonova AS; Sun D; Golemis EA
Cell Signal; 2020 Mar; 67():109497. PubMed ID: 31830556
[TBL] [Abstract][Full Text] [Related]
16. TRAF3 delays cyst formation induced by NF-κB signaling.
Sun L; Hu C; Zhang X
IUBMB Life; 2017 Mar; 69(3):170-178. PubMed ID: 28185403
[TBL] [Abstract][Full Text] [Related]
17. A study of sirolimus and mTOR kinase inhibitor in a hypomorphic
Holditch SJ; Brown CN; Atwood DJ; Lombardi AM; Nguyen KN; Toll HW; Hopp K; Edelstein CL
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F187-F196. PubMed ID: 31042058
[TBL] [Abstract][Full Text] [Related]
18. Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease.
Raman A; Reif GA; Dai Y; Khanna A; Li X; Astleford L; Parnell SC; Calvet JP; Wallace DP
J Am Soc Nephrol; 2017 Sep; 28(9):2708-2719. PubMed ID: 28522687
[TBL] [Abstract][Full Text] [Related]
19. miR-25-3p promotes proliferation and inhibits autophagy of renal cells in polycystic kidney mice by regulating ATG14-Beclin 1.
Liu G; Kang X; Guo P; Shang Y; Du R; Wang X; Chen L; Yue R; Kong F
Ren Fail; 2020 Nov; 42(1):333-342. PubMed ID: 32340512
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
